Haemodialysis effects on lipids Profile in patients with advanced renal disease

  • Salam Nahi Habbob 2Qalat Sukkar Sector Primary Health Care, The Department of Health Thiqar Governorate, Ministry of Health and Environment, Thiqar, Iraq.
  • Sajedha A.H. Khalil 1Medical Laboratory Tech.Dept, College of Health and Medical Technology, Middle technical university, Baghdad, Iraq.
Keywords: : Renal diseases, Haemodialysis, , Cholesterol, Triglyceride.


This study attempts to investigate lipid profile (cholesterol, triglyceride, high density lipoprotein –cholesterol (HDL-C), low-density lipoprotein-cholesterol (LDL-C) and very low-density lipoprotein-cholesterol (VLDL-C)) would be induced potential due to haemodialysis program. The study included hundred and thirteen (113) samples. Eighty-three (83) patients with end stage renal disease on haemodialysis program including (47) males and (36) females with a mean age of (43.3±18.0) years and range from (20-65) years. All the patients had been on dialysis twice per week for two hours each time. In addition, thirty from healthy volunteers as control. All subjects were under obligation fasting for twelve hours and the samples were drowning before and 30 minutes after haemodialysis. Evaluation of serum concentrations of cholesterol, triglyceride, HDL-C, by enzymatic method while LDL-C and VLDL-C were calculated by the Friedewald formula. This study revealed that the changes of lipid profile (cholesterol, triglyceride, HDL-C, LDL-C and VLDL-C) were varied from small changes that statistically not significant between patients up to the highly significant changes between cholesterol and LDL-C before haemodialysis when compared to control. Significant changes are noticed between triglyceride and VLDL-C with control whereas high-density lipoprotein cholesterol didn't change. In male patient’s cholesterol and low LDL-C showed highly significant difference however the rest showed no significant difference. As well as pre and post haemodialysis when compared to control whereas in female lipid profile didn’t show any change.  According to age group (20-35) there was a highly significant difference between pre and post haemodialysis compared to control in cholesterol, triglyceride and LDL-C but not in HDL-C. The other two age groups the lipid profile did not show any changes.


National Kidney and Urologic Diseases Information Clearinghou- se. NIH Publication (2003) No. 03–4894.

Kishimoto TK, Viswanathan K, Ganguly T et al. (2008). "Contam-inated heparin associated with adverse clinical events and activat- ion of the contact system". N Engl J Med 358 (23): 2457–67.

Mehta RL: Therapeutic alternatives to renal replacement therapy for critically ill patients in acute renal failure. Semin Nephro 1994, 14:64–82.

Weinreich T, De los Ríos T, Gauly A, et al. (2006). "Effects of an increase in time vs. frequency on cardiovascular parameters in chronic hemodialysis patients". Clin. Nephrol. 6 (6): 433–9.

National Kidney and Urologic Diseases Information Clearinghou- se guidance Kidney Failure: Choosing a Treatment That’s Right for You

Graham T. The Bakerian lecture: on osmotic force. Philosophical Transactions of the Royal Society in London. 1854; 144:177–228.

Abel, J. J., Rountree, L. G., and Turner, B. B. The removal of diff- usible substances from the circulating blood by means of dialysis. Tn. Assoc. Am. Phys., 28:51, 1913.

Kallenbach J.Z. In: Review of hemodialysis for nurses and dialysis personnel. 7th ed. St. Louis, Missouri: Elsevier Mosby; 2005.

William McClellan, Bessie Young. “The Kidneys and How They Work". NIH Publication (2009) N. 09–3195.

National Kidney Foundation (2002). "K/DOQI clinical practice guidelines for chronic kidney disease".

E. P. Reddy, M. M. Suchitra, V. S. Reddy, et al. Dyslipide- mia: End Stage Renal Disease and Hemodialysis. The Internet Journal of Nephrology. 2009 Volume 5 Number 1.

Attman PO, Samuelsson O, Alaupovic P. Lipoprotein met- abolism and renal failure. Am J Kidney Dis 1993; 21: 573-592.

Attman PO, Samuelsson OG, Moberly J, et al. Apolipoprot- ein B-containing lipoproteins in renal failure: the relation to mode of dialysis. Kidney Int 1999; 55:1536-1542.

A M Rao, A R Bitla, E P Reddy, et al. ʺLipid abnormalities, lipoprotein (a) and apoprote- in pattern in non-dialyzed patients with chronic kidney diseaseʺ. Indian Journal of Clinical Biochemistry, 2010. 25 (1) 47-50.

Mirjana Jugovi, Vesna Spasojevi-Kalimanovska, Slavica Spasi, et al. ʺLipoprotein metabolism abnormalities in patients with chronic renal insufficiency”. Jugoslov. Med. Biohem. 2002. 21: 323– 330.

Ashfaq Altaf, Abdul Halim, Dilshad Ahmad Khan, et al. "Assessment of lipid dysfunction in patients on maintenance haemodialysis”. J Ayub Med Coll Abbottabad 2007; 19(4).

Mateus Martins Prata, Célia Madeira, Otilia Vicente, et al. Lipid profile in haemodialysis patients treated with recombinant human erythropoietin. Neohrol Dial Transplant 1998; 13: 2345-2347.

Nelva T. de Gomez Dumm, Ana M. Giammona, Luis A. Touceda, et al." Lipid abnormalities in chronic renal failure patients undergoing hemodialysis". MEDICINA (Buenos Aires) 2001; 61: 142-146